https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Benefits and harms of prostate specific antigen testing according to Australian guidelines https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53768 Wed 28 Feb 2024 15:52:43 AEDT ]]> Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47693 Wed 25 Jan 2023 08:42:41 AEDT ]]> Increased risk of suicide in New South Wales men with prostate cancer: analysis of linked population-wide data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32834 Wed 19 Jan 2022 15:17:36 AEDT ]]> Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51025 Wed 16 Aug 2023 10:02:34 AEST ]]> Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15668 Wed 11 Apr 2018 16:26:48 AEST ]]> Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26748 Wed 11 Apr 2018 16:04:18 AEST ]]> Clinician-led improvement in cancer care (CLICC) - testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial - study protocol https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16763 Wed 11 Apr 2018 15:41:59 AEST ]]> Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14762 Wed 11 Apr 2018 14:39:01 AEST ]]> Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30808 Wed 11 Apr 2018 12:31:21 AEST ]]> Prostate cancer prevalence in New South Wales Australia: a population-based study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27110 Wed 11 Apr 2018 10:19:36 AEST ]]> New challenges in psycho-oncology research III: a systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33370 Wed 09 Feb 2022 15:55:29 AEDT ]]> Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33342 Thu 28 Oct 2021 13:04:32 AEDT ]]> Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36284 Thu 27 Jan 2022 15:57:32 AEDT ]]> Phase of care prevalence for prostate cancer in New South Wales, Australia: a population-based modelling study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30963 Thu 17 Feb 2022 09:26:28 AEDT ]]> Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48858 Thu 13 Apr 2023 13:29:31 AEST ]]> Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36717 Thu 09 Dec 2021 11:03:35 AEDT ]]> Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35014 Thu 09 Dec 2021 11:01:40 AEDT ]]> Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51488 Thu 07 Sep 2023 10:52:02 AEST ]]> Geographic variation in prostate cancer survival in New South Wales https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18856 Sat 24 Mar 2018 08:03:08 AEDT ]]> Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23724 Sat 24 Mar 2018 07:16:57 AEDT ]]> Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23698 Sat 24 Mar 2018 07:13:26 AEDT ]]> Urologists’ referral and radiation oncologists’ treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41232 P < 0.001). Conclusion: Only 30% of patients with high-risk features are referred to a radiation oncologist with the likelihood of referral being influenced by the perceived risk of cancer-recurrence as well as the urologist’s institutional/personal preference. When patients are seen by a radiation oncologist, 61% receive radiotherapy within 6 months after RP with the likelihood of receiving radiotherapy not being heavily influenced by increasing risk of recurrence. This suggests many suitable patients would receive radiotherapy if referred and seen by a radiation oncologist.]]> Fri 29 Jul 2022 13:51:38 AEST ]]> A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44096 p < 0.001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR=1.06; 95% CI [0.74 to 1.51]; p=0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p=0.001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). Conclusions: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists' attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect.]]> Fri 07 Oct 2022 08:50:21 AEDT ]]>